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COUP-TFPluripotent stem cells display a unique expression pattern of microRNAs (miRNAs). These ~22 nucleotide
non-coding RNAs have established a crucial role in controlling gene expression of pluripotent stem cells at
the post-transcriptional level. Recent studies made important advances in identifying miRNA regulated pro-
cesses like de novo DNAmethylation, progression of the cell cycle and regulation of cell fate decision. miRNAs
have also the ability to reprogram somatic cells to pluripotent stem cells and on the other hand, to induce dif-
ferentiation of pluripotent stem cells into distinct somatic lineages. Previously it was published that miRNAs
can direct reprogramming on its own. Here we provide evidence and critically discuss that the effect of
miRNA depends on co-expression of the classical reprogramming factors. During transition between these
different cell fates distinct miRNAs adjust the levels of speciﬁc transcriptional programs and confer robust-
ness to differentiation processes. This results in a complex network between miRNAs and their targets. The
fact that miRNAs itself can also be regulated by its targets establishes complex regulatory loops. Based on
bioinformatical predictions, each miRNA theoretically has hundreds of target genes making it even more
challenging to understand the complete network between miRNAs and their targets.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Pluripotent cells are capable to differentiate into all cell types
within the body including the germ cells. These characteristics are
displayed by cells of the inner cell mass (ICM) from early embryos en-
abling them to form the complete adult organism. The pluripotent
state of cells from the ICM can be captured in vitro by placing blasto-
cysts in culture, leading to the generation of pluripotent embryonic
stem cells (ESCs) [1].
Thederivation of complete animals by transplantation of somatic nu-
clei into eggs was the ﬁrst demonstration that cell fates are neither re-
stricted nor irreversible [2]. Subsequent work demonstrated that the
determined fate of differentiated cells can be reversed by nuclear trans-
fer, cell fusion or iPS (induced pluripotent stem cell) technology [2–6].
These approaches offer the opportunity to generate pluripotent
embryonic-like cells from adult, somatic cells of the same individual,
opening the ﬁeld of personalized regenerative medicine. Furthermore,
the developments in this ﬁeld have been honored by the Nobel Prize
for Physiology or Medicine in 2012. The Nobel Prize was awarded to
Sir John Gurdon, who cloned a frog by nuclear transfer in 1962 [7] and
to Shinya Yamanaka, who invented iPS technology [6].: +49 521 106 5654.
altschmidt).
f Wuerzburg, Versbacherstr. 5,
l rights reserved.In contrast to nuclear transfer and cell fusion, induced pluripotent
stem cells (iPSCs) are generated by overexpression of the transcrip-
tion factors Oct4, Sox2, Klf4 and c-Myc and do not rely on the usage
of unfertilized eggs making them ethically less controversial. On the
other hand, iPSC generation is less efﬁcient, appears to be slower
and it still remains questionable if iPSCs are in full terms equivalent
to ESCs or pluripotent cells derived by nuclear transfer [8,9]. Several
studies indicate that subtle differences in gene expression and chro-
matin modiﬁcations lead to partially reprogrammed iPSCs, which re-
tain an epigenetic memory [10–12]. This manifests in the tendency of
tissue-speciﬁc iPSCs to more efﬁciently differentiate to somatic cells
of their tissue of origin. Reduced pluripotency has also been associat-
ed with loss of imprinting at the Dlk1–Dio3 locus [13]. iPSC lines that
lost imprinting at this speciﬁc locus poorly contributed to chimeric
mice and were not able to generate “all-iPSC mice” in tetraploid com-
plementation assays [13]. This study also demonstrates the power of
tetraploid complementation assays to investigate full developmental
potential of iPSCs. Subsequent investigations suggest that imprinting
at the Dlk1–Dio3 locus is not an absolute marker for pluripotency. Ex-
pression and stoichiometry of reprogramming factors as well as other
parameters rather seem to inﬂuence the grade of pluripotency [14].
So far it remains unclear whether such subtle biological differences
between ES cells and fully reprogrammed iPSCs have any functional
consequences, which might challenge the use of iPSCs in disease re-
search [11,15]. Nevertheless, some promising reports carried out
with ESCs demonstrated that pluripotent cells are capable to differen-
tiate into speciﬁc cell types in vitro which are capable to integrate and
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models [16,17].
The regulation of pluripotency is controlled by a complex regulatory
network including several transcription factors and chromatin modify-
ing enzymes. The core transcriptional network consists of Oct4, Nanog
and Sox2. All three transcription factors are highly expressed in the
ICM, epiblast and undifferentiated ESCs. Disruption of each of these
genes in mice results in early embryonic lethality due to loss of plurip-
otent cells within the ICM of preimplantation embryos [18,19]. While,
c-Myc and Klf4 are used in some reprogramming approaches starting
with ﬁbroblasts those seem not to be part of the core transcriptional
network in ESCs. In fact even Oct4 alone is able to reprogram
neuroectodermal cells from mice and men. The transcriptional regula-
tion of pluripotency and the unique chromatin status of pluripotent
cells as well as the different states of pluripotency are extensively
reviewed elsewhere [20–24].
Another important role in the regulation of pluripotency and line-
age speciﬁcation has recently emerged for non-coding microRNAs
that are associated with the main regulatory circuitry by modulating
gene expression at the post-transcriptional level (Fig. 1) [25]. This re-
view focuses on the emerging role of miRNAs in cell fate regulation of
pluripotent stem cells. Within the next chapters miRNA mediated
regulation of pluripotency and reprogramming is introduced and
miRNA mediated cell fate speciﬁcation will be discussed.2. Biogenesis of miRNAs in mice and men
MicroRNAs (miRNAs) were initially discovered in Caenorhabditis
elegans during a genetic screen to uncover molecules involved in the
regulation of nematode development [26]. Since then, a fundamental
role has been established for these small ~22 nucleotide non-coding
RNAs in controlling gene expression at the post-transcriptional level.
Hundreds of miRNAs have been discovered in most eukaryotic species
[27], located in intergenic regions as well as in exons or introns of
other genes.
Most miRNAs are transcribed by Polymerase II as long primary,
capped and polyadenylated transcripts (pri-miRNAs) [28], which
are processed into their mature form in a complex multistep process.
Brieﬂy, within the nucleus, the pri-miRNA is converted by a
microprocessor-complex to the precursor miRNA (pre-miRNA). The
microprocessor-complex consists of the RNase type III endonuclease
Drosha, which is associated to the Di George syndrome critical region
gene 8 (DGCR8) and additional co-factors. This complex recognizes
the hairpin secondary structures embedded in the pri-miRNA [29–32].
The resulting ~70 nucleotide hairpin pre-miRNA is excised from the
pri-miRNA and recognized by the Exportin-5/Ran-GTP complex, active-
ly exporting the pre-miRNA out of the nucleus [33–35]. A small subclassFig. 1. Differentiation of embryonic stem cells (ESCs). Embryonic stem cells are charac-
terized by a transcriptional network involving the transcription factors Oct4, Sox2 and
Nanog, which are downregulated in many cell types during differentiation. The inverse
process (reprogramming) can be initiated by forced expression of some of these factors
in combination with others such as c-Myc and Klf4. Surprisingly, both processes seem
to rely on miRNAs, since knockout of Dicer inhibits both processes.of miRNAs, located in small introns, the so called mirtrons, can bypass
the Drosha-mediated processing, which is crucial for the vast majority
of the other miRNAs [36]. After entering the cytoplasm, the pre-
miRNA is further processed by another RNase-type III enzyme, the so
called Dicer, to its mature ~22 nucleotide miRNA–miRNA⁎ duplex.
Dicer contains a PAZ-domain (Pie/Argonaut/Zwille) recognizing the
3′-overhangs of the pre-miRNAs generated by the microprocessor
[37,38]. The dicer-enzyme cuts the pre-miRNAs within the stem loop
and creates thereby the ~22–24 nucleotide miRNA-duplex, which re-
mains bound to the dicer.
In most cases only one strand of this duplex, the designated
“major” strand, gets incorporated into the multi-protein miRNA ribo-
nucleoprotein complex (miRNP or miRISC complex). The “minor”
strand, referred to as miRNA⁎, gets degraded after exclusion from
the miRISC complex. Some large scale studies provided strong evi-
dence, that the miRNA⁎ strand also has a biological function, since a
larger number of miRNA⁎ sequences could be detected among the
total miRNA population than expected.
The miRNA loaded miRISC complex is used to guide it to its target
sites. Previous studies focused on the target sites within the 3′UTR
(untranslated region) whereby miRNA targeting within the 5′UTR and
cds (coding sequence) has been overlooked. Thus, recent sequencing
data using anti-Ago immunoprecipitation and cross-linking have
reported target sites e.g. in cultivated HEK 293 cells from 5′UTR to cds
and 3′UTR, targeting 4647 transcripts (21% of 22,466 unique HEK293
cell transcripts) [39]. Ago1–4 seemed to bind to the same target se-
quences: 84% of the miRNA target sites were located in exons, whereas
4% bound to 5′UTR, 50% to cds and 46% to 3′UTR. According to data by
Hafner and coworkers miRNA sites in cds seem to result in small signif-
icant mRNA destabilization in HEK293 cells.
Target interaction of miRNA and mRNA seems to involve a
seed-pairing interaction with a match of approximately 7 nt near
the 5′end of the 22nt miRNA (e.g. positions 2–7) with sites in the tar-
get region of mRNA [40]. Targeting-sites that cannot be explained by
the canonical seed-match model seem to involve non-Watson–Crick
base pairing with G-bulges at positions 5–6 and suggest an alterna-
tive mode of microRNA target recognition, making target gene identi-
ﬁcation even more challenging [41].
Initial studies suggested that animal miRNAs exclusively mediate
target gene silencing by translational repression. Recently, there is
growing evidence that animal miRNAs can induce mRNA degradation
as well as translational repression [42]. Translational repression has
been proposed to occur at four different stages: initiation of transla-
tion, elongation of translation, protein degradation during translation
and premature termination of translation. Several studies addressing
this question on a genome-wide scale by mass spectrometry and
transcriptome analysis suggest that miRNA mediated mRNA degrada-
tion alone accounts for most silencing of miRNA targets [43–46]. Nev-
ertheless, the exact molecular mechanisms, which decide at what
stage target gene silencing occurs still remain elusive [42].
3. The overall function of miRNAs in embryonic stem cells
For ESCs distinct miRNA signatures could be identiﬁed, representing a
subset ofmiRNAs speciﬁcally expressed inmESCs and hESCs, respectively
[47–50]. Among miRNA-clusters that are highly enriched in mESCs
are miR-290, miR-17/19, miR-106b/25, miR-106a/363, miR-302b/367,
miR-15b/16 and miR-32. Some of these miRNA families already have
been analyzed and speciﬁc functions have been revealed [51,52].
Several studies addressing the overall function of miRNAs in
mESCs used cell lines deﬁcient for crucial miRNA processing factors
like Dicer or DGCR8 [53–56].
In contrast to DGCR8, which only is involved in processing of
miRNAs [57], Dicer is involved in both miRNA and siRNA pathways.
The phenotype of Dicer deﬁcient cells can therefore be caused by either
the absence of siRNA and/or miRNA. Interestingly, parallel deep-
Table 1
Sequences of mature miRNAs generate by miR-290 cluster.
Name of miRNA Sequence of miRNA
miR-290-3p aaagugccgccuaguuuuaagccc
miR-291a-3p aaagugcuuccacuuugugugc
miR-291b-3p aaagugcauccauuuuguuugu
miR-292-3p aaagugccgccagguuuugagugu
miR-294 aaagugcuucccuuuugugugu
miR-295 aaagugcuacuacuuuugagucu
miR-290-5p acucaaacuaugggggcacuuu
miR-291a-5p caucaaaguggaggcccucucu
miR-291b-5p gaucaaaguggaggcccucucc
miR-292-5p acucaaacugggggcucuuuug
miR-293 acucaaacugugugacauuuug
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only miRNA proﬁles changed in the absence of Dicer. Proﬁles of other
small RNAs e.g. siRNAs seemed not to be affected [58].
Disruption of both Dicer alleles in mice leads to embryonic lethal-
ity, indicating the importance of Dicer and small RNA processing in
mouse development. The possibility to generate homozygous dicer
knockout cell lines suggests that the overall function of miRNAs is
not required for the maintenance of pluripotency, though Dicer−/−
mESCs show severe defects in growth and differentiation. Dicer-null
mESCs fail to differentiate to embryoid bodies (EBs) accompanied
with the lack of markers for the endodermal (Hnf4) and mesodermal
(T-brachyury, Bmp4 and GataI) lineage [56]. Loss of Dicer also affects
the progression of the cell cycle, resulting in a prolonged G1 and GO
phase which compromises the proliferation of Dicer−/− mESCs [54].
The importance of miRNAs in regulating cell cycle progression is
also stressed by the fact that almost 50% of all miRNA molecules iden-
tiﬁed by massive parallel RNA sequencing are produced at four loci
(miR-21, miR-17/92 cluster, miR-15b/16 cluster and miR-290 clus-
ter), that are involved in regulation of cell cycle and oncogenesis [58].
Controversial results regarding the effect of loss of Dicer on the
epigenetic modiﬁcation of centromeric DNA were described. On the
one hand, a reduction in DNA methylation and histone modiﬁcation
of centromeric repeat sequences was described [56], whereas another
study reported that loss of Dicer affects the abundance of transcripts
from centromeres without affecting histone modiﬁcations or DNA
methylation of centromeric DNA [54].
Disruption of the Dgcr8 gene also results in a global defect of
miRNA maturation, indicated by the complete absence of neither
fully mature nor intermediate pre-miRNA products [53]. Similar to
loss of Dicer, Dgcr8 knockout embryos die during early development
and like Dicer−/−mESCs, Dgcr8−/−mESCs display defects in differen-
tiation and cell cycle progression. Dgcr8−/− deﬁcient mESCs accumu-
late in the G1 phase of the cell cycle and showed a delay in the
upregulation of differentiation markers after withdrawal of LIF in EB
cultures. Furthermore, Dgcr8−/− was not able to generate teratomas
after subcutaneous injection, further stressing the observed differen-
tiation defect. Both studies demonstrate that complete loss of miRNAs
in ESCs compromises the exit of self-renewal during initiation of dif-
ferentiation as well as the fast progression of the cell cycle.
Exit from self-renewal of Dgcr8−/− mESCs can be promoted by in-
troduction of the let-7 miRNAs into DGCR8 deﬁcient mESCs. The let-7
miRNA family is highly expressed in somatic cells and represses genes
involved in self-renewal. The inhibitory effect of let-7c on self-renewal
can be rescued by co-transfection of let-7 and miR-294, a member of
the ESC speciﬁc miR-290 cluster. Introduction of miR-294 indirectly en-
hances the expression of Lin28 and c-Myc. Lin 28 is known to directly
block the maturation of let-7 [59,60], whereas c-Myc together with
n-Myc for the transcriptionally activates the miR-290 cluster [25,61].
The let-7 miRNA family thereby gets silenced and self-renewal is
maintained.
During differentiation self-renewal normally becomes inhibited
by downregulation of Oct4, Sox2 and Nanog resulting in a decrease
of Lin28 and miR-290 cluster expression. Without Lin28, let-7 matu-
ration is not blocked any longer, resulting in the further suppression
of self-renewal promoting genes. These results demonstrate that
self-renewal is regulated by opposing miRNA families. The let-7
miRNA family is required for inhibition of self-renewal, which is nor-
mally initiated during differentiation, whereas miR-290 cluster indi-
rectly represses let-7 function in the state of self-renewal. Depletion
of all miRNAs in ESCs therefore results in an undifferentiated state
with no exit from self-renewal (Fig. 1).
Deletion of crucial miRNA processing factors like Dicer or DGCR8
[53–56] also enables the investigation of distinct miRNA families.
This strategy leads to an identiﬁcation of important cellular functions
of the ESC speciﬁc miR-290 cluster, which is discussed in more detail
within the following section.ThemurinemiR-290 clusterwas initially identiﬁed as a 2.2-kb region
on chromosome 7 [47,62]. The spliced, capped and polyadenylated pri-
mary transcript produced at this locus gives rise to 14 mature miRNAs.
Among these, miR-290-3p, miR-291a-3p, miR-291b-3p, miR-292-3p,
miR-294 and miR-295 share the hexamer seed ′AAGUGC′ (Table 1).
The other miRNAs of the miR-290 cluster (miR-290-5p, miR-291a-5p,
miR-291b-5p, miR-292-5p, miR-293, miR-293*, miR-294⁎ and
miR-295⁎) differ in their seed but are still highly expressed in ESCs
with the exception of the hardly detectable minor forms of miR-293,
miR-294 and miR-295 (miR-293⁎, miR-294⁎ and miR-295⁎) [48].
Expression of this miRNA cluster is downregulated during ESC dif-
ferentiation and not detectable in adult mouse organs [47]. The
miR-290 cluster contributes to about 60% of the complete miRNAs
in mESCs making it the most abundant miRNA family in mESCs [25].
Though its structure stays highly variable, the miR-290 cluster is con-
served among human, chimpanzee, rat, mouse, dog and cow but stays
restricted to placental mammals [62,63]. Sequence comparisons indi-
cated that the mouse homologue of miR-290–295 is present at two
human loci, the highly similar miR-371 cluster and the moderately
similar miR-512 cluster.
Recent studies reported that miR-290 cluster regulates various im-
portant cellular processes by post-transcriptional inhibition of a broad
range of different target genes. Two independent studies revealed the
regulation of de novo DNA methylation by miR-290 cluster using Dicer
deﬁcient mESCs [64,65]. Microarray data indicated a downregulation
of methyltransferases (Dnmt3a, Dnmt3b and Dnmt3l), which could be
rescued by overexpression of miR-290 cluster, indicating an indirect
control of the expression of methyltransferases by miR-290 cluster
[64]. Retinoblastoma-like 2 (Rbl2), a known transcriptional repressor
[66], was identiﬁed as a potential miR-290 cluster target with two con-
served binding sites within the 3′UTR. Transfection of siRNAs directed
against Rbl2 resulted in an increase of Dnmt, supporting the hypothesis,
that Rbl2 is amiR-290 cluster target that acts as a repressor of Dnmt ex-
pression, resulting in a decreased methylation in Dicer−/−mESCs. Dur-
ing in vitro differentiation of these cells, expression of Oct4 is only
partially decreased, caused by amissing de novomethylation of its pro-
moter. This defect could be rescued by transfection of all three
methyltransferases as well as by transfection of the miR-290 cluster.
This favors strongly the notion, that the defect in the methylation of
the Oct4 promoter is a result of a repressed expression of
methyltransferases [64]. Therefore, in Dicer−/− cells, a reduced
miR-290 cluster expression causes an improper silencing of Rbl2,
which is responsible for the transcriptional repression. Another study
also described such defects inDicer−/− cells and identiﬁed Rbl2 as a tar-
get of miR-290 cluster, indirectly affecting telomerase-length homeo-
stasis as a result of a global decreased DNA methylation [65]. Another
important function of miR-290 cluster is the regulation of G1/S transi-
tion in ESCs, ensuring a rapid proliferation [67]. Dgcr8 knockout
mESCs, lackingmicroprocessor activity and hence all canonicalmiRNAs,
were used to study the proliferation defect. p21, an inhibitor of the
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ter. Knockdown of p21 as well as overexpression of members of the
miR-290 cluster enabled a rescue of the defect in proliferation, indicat-
ing the importance of miR-290 cluster for the rapid proliferation of
mESCs [67].
Besides regulating de novo DNA methylation and the G1/S transi-
tion, miR-290 cluster has also been linked to cell survival by
protecting mESCs against genotoxic stress and thereby preventing
apoptosis. This protective effect is mediated by direct repression of
Caspase 2 and Ei24, which are activated upon damage of DNA [68].
miR-290 cluster deﬁciency in developing mice leads to a partially
penetrant embryonic lethality and defective germ cells, indicating an
important role for miR-290 cluster in early mouse development [69].
Notably, mESCs deﬁcient for the miR-290 cluster could be generated
and showed no obvious defects.
Members of themiR-290 clusterwere also demonstrated to enhance
the efﬁciency of reprogramming somatic cells to induced pluripotent
stem cells, a recently described process, which is introduced in the
next chapter.
4. Diverse functions for miRNAs in reprogramming
Besides deriving ESCs from the ICM of early embryos, pluripotent
cells can also be generated by overexpression of the transcription fac-
tors Oct4, Sox2, Klf4 and c-Myc [6,70]. Somatic cells can be
reprogrammed by these factors to induced pluripotent stem cells
(iPSCs), which have all distinct features with “naïve” mESCs in com-
mon. iPSCs are able to contribute to chimeric mice, show the expres-
sion of key pluripotency markers and both X-chromosomes are
activated in female cells [71]. Furthermore, full developmental poten-
tial of iPSCs was demonstrated by tetraploid complementation creat-
ing mice entirely derived from iPSCs [72–74].
Since its ﬁrst description in 2006 by Takahashi and Yamanaka [6],
different combinations of genes including Nanog, Esrrb, Nr5a2, Lin28
and E-cadherin have been used to reprogram ﬁbroblasts and other
types of somatic cells [75–78]. To induce pluripotency in neural
stem cells (NSCs) even Oct4 alone seems to be sufﬁcient [79].
Among all factors used for induction of pluripotency, Oct4 is the
only one, which cannot be replaced by other factors. This indicates a
unique role for Oct4 during reprogramming [80]. The mechanism by
which the indicated factors accomplish the dedifferentiation and es-
tablishment of the pluripotent state is poorly understood but involves
reactivation of the endogenous pluripotency genes, massive chroma-
tin remodeling and morphological changes towards an epithelial
phenotype.
Various small molecules and speciﬁc miRNAs were employed in
the improvement of the efﬁciency of reprogramming [81–85]. During
reprogramming of mouse embryonic ﬁbroblasts (MEFs), a subset of
miRNAs belonging to the miR-290 cluster (miR-291-3p, miR-294
and miR-295) was able to signiﬁcantly enhance the colony number
of induced pluripotent stem cells (iPSCs) [82]. Transient transfection
of miR-291-3p, miR-294 or miR-295 at day 0 and 6 post-infection
with the reprogramming cocktail consisting of Oct4, Klf4 and Sox2
(OKS) enhanced the induction of pluripotency, whereas two miRNAs
of the same cluster with different seed sequences had no effect. The
strongest effect was observed after OKS transduction with addition
of miR-294 and iPSCs generated by this approach were injected into
blastocysts conﬁrming pluripotency of these cells by contribution to
all three germ layers as well as the germ line. Though miR-294 is
able to replace c-Myc during the process of reprogramming, the
mechanisms by which canonical members of the miR-290 cluster
can substitute c-Myc remain elusive [82].
The binding of c-Myc to the promoter of these miRNAs suggests
that miR-291-3p, miR-294 and miR-295 act downstream of c-Myc,
though the effects of c-Myc and the indicated miRNAs on the cell pop-
ulation are not identical. Unlike c-Myc, miR-294 did not induceproliferation of MEFs during the early phase of dedifferentiation. Fur-
thermore, in contrast to exogenous c-Myc, miR-294 yielded a homog-
enous population of iPSC colonies. These data indicate overlapping as
well as independent functions of c-Myc and miR-294 during the pro-
cess of reprogramming [82].
Three studies so far even suggested that induction of pluripotency is
possible by miRNAs alone [86–88]. Retroviral mediated overexpression
of miR-302/367 cluster was demonstrated to be sufﬁcient to induce
pluripotency of mouse and human ﬁbroblasts without exogenous
expression of other transcription factors [86]. Pluripotency of miRNA-
mediated reprogrammed iPSCs was conﬁrmed by teratoma formation
for human iPSCs and contribution to chimeric mice as well as
germ-line contribution for mouse iPSCs. Notably, the efﬁciency in
reprogramming was claimed to be two magnitudes higher in compari-
son to the usual approach using Oct4, Klf4, Sox2 and c-Myc [86]. Tran-
sient transfection of a combination of mature miR-200c, miR-302 and
miR-367 was also used to induce pluripotency of mouse and human
somatic cells without integration of any viral-based vectors [88]. Never-
theless, miRNAmediated reprogrammingwas not used in other studies
so far, making it a very controversial issue in this ﬁeld. We and our
collaborators were not able to reproduce the published results in
our laboratories. Though additional expression of miR-302 cluster
and miR-290 cluster leads to a slight increased reprogramming
efﬁciency when using Oct4-GFP mouse ﬁbroblasts with the classical
reprogramming factors Oct4, Sox2, Klf4 and c-Myc (OSKM) (Fig. 2).
Nevertheless, both miRNA clusters fail to induce pluripotency with-
out additional factors (unpublished data, Fig. 2). Furthermore,
reprogramming of human ﬁbroblasts with OSKM and miR-302/367
leads to an enhanced expression of TRA-1–60 from 5.7% to 13.3%
(unpublished data, Dr. Holm Zaehres, Prof. Dr. Hans Schöler,
Department Cell and Developmental Biology, Max–Planck-Institute
for Molecular Medicine, Münster, Germany). Again miR-302/367
alone did not induce reprogramming (personal communication,
Dr. Holm Zaehres). Further work has to be carried out, to solve the
question why miRNAs alone are not able to reprogram ﬁbroblast
to iPS cells without the classic reprogramming factors.
Another study indicating the importance of miRNAs in
reprogramming demonstrated that ﬁbroblasts lacking all mature
miRNAs are not able to generate iPSCs [89]. Therefore, miRNAs are
not only necessary for proper differentiation of pluripotent cells, but
also play a crucial role during de-differentiation of ﬁbroblasts
[55,89] (Fig. 1).
Deﬁning the target genes of miRNAs during the induction of
pluripotency provides further insight into the mechanism of
reprogramming. Indeed, various studies revealed a role for distinct
miRNAs in the establishment of an epithelial character during
reprogramming of MEFs [83–85]. These reports underline the emerg-
ing notion that pluripotency is closely related to an epithelial pheno-
type and that reprogramming requires a mesenchymal to epithelial
transition (MET).
During development epithelial to mesenchymal transitions (EMTs)
and mesenchymal to epithelial transitions (MET) are naturally occur-
ring processes, which involve dramatic cytoskeletal and morphological
changes enabling adoption to speciﬁc cell fates for proper formation of
organs and tissues. The discovery of MET as an early event during
reprogramming of ﬁbroblasts, which represent a typical mesenchymal
phenotype, leads to the emerging notion that pluripotency is closely re-
lated to an epithelial phenotype.
Loss of the epithelial character is characterized by EMT. This pro-
cess involves an upregulation of Snail, Slug and Zeb transcription fac-
tors which repress the transcription of E-cadherin, followed by the
loss of cell adhesion and massive cytoskeletal rearrangements. As a
result, cells acquire a motile phenotype. EMTs occur at different
stages during development and cancer progression and different sig-
naling pathways like TGF-β, NF-κB or Wnt are known as potential
EMT inducers [90].
Fig. 2. Reprogramming with miR-290 cluster and/or miR-320 cluster failed to induce pluripotency. Doxycycline-inducible lentiviral vectors were used to express miR-290 and/or
mir-302 cluster. Left image shows the expression of miR-290 cluster after induction with doxycycline (DOX). Reprogramming efﬁciency of Oct4-GFP mouse ﬁbroblasts with Oct4,
Sox2, Klf4 and c-Myc (OSKM) could be only slightly enhanced by the additional expression of miR-290 and/or miR-302 cluster (right images). Reprogramming strategies using
miR-290 cluster and/or miR-302 cluster alone failed to reprogram ﬁbroblast to iPSCs (Hauser et al., unpublished data).
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a high expression of E-cadherin, resembling rather characteristics
shared with an epithelial phenotype than a mesenchymal one.
These characteristics easily enable morphological and cytoskeletal
adjustment triggered by speciﬁc cues during differentiation and fur-
thermore this morphology is likely an adaption to the fast progressing
cell cycle of ESCs since each mitotic division requires massive cyto-
skeletal rearrangements.
So far it remains unclear whether the epithelial character of plu-
ripotent cells is directly involved in cell signaling and maintenance
of pluripotency or if this is just a result of the undifferentiated, plurip-
otent state.
During the initial phase of reprogramming several miRNA families
could be identiﬁed as mediators of MET. Among them, miR-205 and
the miR-200 clusters were investigated in more detail. Both were in-
duced by BMP-signaling, which is also known in participating in the
maintenance of pluripotency in addition with LIF. A MET occurs as
an early event during reprogramming and seems to have an initiating
character on the induction of pluripotency [84]. Suppression of
reprogramming by BMP antagonists could be rescued by transfection
of mimics for miR-200b and miR-200c. As previously reported, the
miR-200 family directly targets the E-cadherin repressors Zeb1 and
Zeb2, as well as Snail and Slug, key regulators of EMT [91–94] and
thereby triggers the conversion to an epithelial phenotype.
In addition to miR-200 cluster, several other miRNA clusters were
identiﬁed as potential enhancers of reprogramming. Expression anal-
ysis of miRNA clusters that were highly expressed in mESCs during
the initial phase of reprogramming revealed an induction of
miR-17/92, miR-106b/25, miR-106a/363, and miR-302b/367 within
the ﬁrst four days of the reprogramming process [83]. Further inves-
tigation of miR-106b/25 cluster suggested an enhancement of iPSC in-
duction by promoting MET. Transfection of mimics for miR-93 and
miR-106b promoted an increase in the colony number of iPSCs,
whereas inhibition of the indicated miRNAs resulted in a decrease
of the colony number. Tgfbr2 and p21were identiﬁed as direct targets
of miR-93 and miR-106b and subsequent siRNA-mediated knock-
down of both genes resulted in an increase of iPSC colony number.
In contrast, overexpression of TGF-β receptor II diminished the im-
proving effect of miR-106b. In agreement with the notion that MET
is an initiating event during induction of pluripotency, these data in-
dicate that miR-106b/25 cluster promotes the establishment of an ep-
ithelial phenotype by inhibition of TGF-β signaling, a known inducer
of EMT [90].
Tgfbr2 was also discovered to be a target of the human miR-302b
and miR-372. During reprogramming of human ﬁbroblasts [85],
transfection of both miRNAs at days 2 and 7 after infection with the
reprogramming cocktail enhanced the number of colonies with a
hESC like morphology [85]. Among different potential target genes
identiﬁed by expression analysis, Tgfbr2 and Rhoc were validated by
reporter assays and mutation of miRNA binding sites. Furthermore,miR-302b, miR-372 and miR-294, which share the same seed se-
quences, were able to block TGF-β induced epithelial to mesenchymal
transition in HaCaT cells. Notably, a modiﬁed form of miR-294 with a
mutated seed sequence was not able to inhibit a TGF-β mediated ep-
ithelial to mesenchymal transition [85], indicating the importance of
the seed sequence for probable targeting of these miRNAs
Another miRNA family (miR-130/301/721) regulating induction of
iPSCs was recently identiﬁed in a miRNA library screen [95]. miR-130/
301/721 enhances the efﬁciency of iPSC generation by repressing the ho-
meobox transcription factor Meox2. Overexpression of miRNA-resistant
Meox2 abolished the effect of miR-130/301/721 on iPSC formation. It is
unclear, how Meox2 interferes with reprogramming, but Meox2 might
inhibit TGF-β signaling or help overcome p21 mediated cell cycle arrest
[95].
In contrast to enhancing the generation of iPSCs, some miRNA fam-
ilies (miR-34, miR-21 and miR-29a) interfere with reprogramming
[96,97]. Inhibition of these miRNAs results in an enhanced
reprogramming efﬁciency. MEFs with a genetic ablation of miR-34a
exhibited an increased reprogramming efﬁciency, suggesting that
miR-34a interferes with reprogramming. miR-34 cluster consists of
miR-34a, miR-34b and miR-34c. Knockout of miR-34a or miR-34a/b
promotes reprogramming of somatic cells while ablation of miR-34a
showed a stronger effect on iPSC generation than miR-34b and
miR-34c. MEFs deﬁcient for all three miRNAs exhibited the greatest ef-
fect on reprogramming. Deﬁciency of thesemiRNAs also results inmore
rapid kinetics during reprogramming. miR-34 cluster was previously
identiﬁed as bona ﬁde target of p53 [98], a known repressor of
reprogramming [99–101]. Therefore, miR-34 cluster seems to act in re-
sponse to p53 to repress its target genes. Among these targets, Sox2,
Nanog andN-Mycwere identiﬁed to bepost-transcriptionally regulated
by miR-34 cluster during induction of iPSCs [97].
Further examples for miRNAs interfering with iPSC generation are
miR-21 and miR-29a [96]. Both miRNAs are abundantly expressed in
MEFs. Depletion of bothmiRNAs results in an enhanced reprogramming
efﬁciency mediated by regulation of p53 and ERK1/2 pathways. Nota-
bly, c-Myc seems to repress MEF enriched miRNAs like miR-21 and
miR-29a to promote reprogramming [96]. Both studies suggest that
miRNAs are not only involved inmaintaining the undifferentiated cellu-
lar state, but also trigger maintenance of the differentiated cell fate
(Fig. 5).
5. miRNA mediated cell fate determination
Besides being involved in the regulation of pluripotency, there is
increasing evidence that miRNAs also play a crucial role in the cell
fate speciﬁcation during differentiation of pluripotent cells and
more restricted progenitor cells (Fig. 5). This is either by inhibiting
distinct differentiation processes or by promoting the exit of
self-renewal and commitment to speciﬁc lineages. Conversion of plu-
ripotent stem cell to distinct lineages enables the identiﬁcation of
Fig. 3. Regulation of cell fate by COUP-TFII and miRNA 302. Orphan nuclear receptor
COUP-TFII (also called NR2F2) can shift cell fate in ES cells to neuroectoderm. Within
pluripotent ES cells a network of transcription factors such as Oct4, Sox2 and Nanog di-
rect the expression of miR 302/367 cluster. From this cluster miR 302 is processed
which represses translation of COUP-TFII. Furthermore COUP-TFII expression is direct-
ly repressed by Oct4. Thereby a feedback loop is created to regulate COUP-TFII mediat-
ed differentiation.
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This opens the opportunity to study individual candidate miRNAs
for their potential to regulate lineage commitment. A large body of
work has been carried out to identity distinct miRNAs and their target
genes. Table 2 gives an overview about several studies identifying
miRNA mediated cell fate regulation. Within the following chapter
we would like to introduce some examples of miRNA mediated cell
fate regulation.
The orphan nuclear receptor NR2F2 (COUP-TFII) is able to pro-
mote neuronal differentiation of ESCs by inducing the expression of
neural genes during early differentiation [102]. Within the undiffer-
entiated state of ESCs, COUP-TFII is inhibited by OCT4 as well as by
miR-302. OCT4 represses COUP-TFII at the transcriptional level,
whereas miR-302 acts on the post-transcriptional level. Conversely,
during differentiation COUP-TFII is able to repress OCT4, creating a
positive feedback loop. Thereby, the OCT4 driven expression of
miR-302 is reduced, resulting in increasing levels of COUP-TFII [102]
(Fig. 3). This regulatory circuitry controls early neuronal lineage com-
mitment in human embryonic stem cells and demonstrates how
ES-speciﬁc miRNAs participate in the maintenance of pluripotency
and also control lineage commitment during exit of self-renewal
(Fig. 5).
Another example how cell fate determination is regulated by
ESC-speciﬁc miRNAs are miR-293 and miR-291b-5p. Both, miR-293
and miR-291b-5p belong to the miR-290 cluster and inhibit the
NF-κB subunit p65 in mESCs (Fig. 4) [103]. Thereby protein levels of
NF-κB/p65 are kept at a low level within the undifferentiated state
of mESCs. To prevent translated NF-κB from activating target gene
transcription, the ESC speciﬁc transcription factor Nanog interacts
with NF-κB by direct protein–protein interaction, which inhibits tar-
get gene activation of NF-κB [104]. Both NF-κB inhibiting pathways,
Nanog and the expression of miR 290 cluster are directly regulated
by the ESC core transcription factors Oct4 and Sox2 [25]. Thus undif-
ferentiated ES cells are functionally null for NF-κB subunits. In this
line forced expression of NF-κB transactivating subunits resulted in
differentiation of mESCs towards a mesodermal lineage [103]. It is
tempting to speculate that miR-290 cluster keeps the p65 protein
level at a certain threshold, which ensures that enough Nanog proteinTable 2
Summary of miRNAs and their corresponding targets involved in cell fate regulation.
MicroRNA Target Process
Let7 TLX Increase
miR-1/miR-206 Klf4 Regulat
miR-7a Pax6 Control
of ventr
miR-9 TLX, Rest, Gsh2, Foxg1 neuroge
miR -9* Co-Rest, BAF53a, BAF45a See abo
miR-10a Bcl-6, Ncor2 Constra
miR-22 HDAC6 Promot
miR-23a cluster Inhibits
miR-23b SMAD 3,4,5 differen
miR-27b Dll4, Spry2 promot
miR-124 BAF53a, BAF45a Promot
miR-125 SMAD4 Early ne
miR-137 LSD1 inhibits
of neura
miR-145 Oct4, Sox2, Klf4 Promot
miR-143 and miR-145 Klf4, ELK1 Promot
miR-290 cluster Rbl2, Cdkn1a, Lats,
caspase 2, Ei24, RelA
De novo
of differ
miR-302 cluster COUP-TFII,
Lefty1, Lefty2
Promot
miR-669a, miR-669q MyoD Prevent
miR-23a, miR-30c, miR-34c,
miR-133a, miR-135a,
miR-205, and miR-217
RUNX2, TRPS1 Block of
mesencis left to act as a transcriptional activator. Nevertheless, it has yet not
been investigated, if NF-κB is able to inhibit Nanog.
Notably, in Drosophila the NF-κB ortholog dorsal has already an
established role for cell fate determination during embryogenesis
[105]. Since Bilateria show a common plan for patterning the dorso-
ventral axis [106], NF-κB might not only regulate cell fate speciﬁca-
tion in ESCs [103,104,107], but also play a role for cell fate
speciﬁcation during developmental processes in vivo (Fig. 4).
Both examples given above describe miRNAs which inhibit distinct
differentiation processes. It is also possible that distinct miRNAs promote
commitment to speciﬁc lineages. This is demonstrated for miR-125b,
which promotes neural lineage commitment by posttranscriptional re-
pression of SMAD4 [108]. miR-125 regulates the levels of SMAD4 in re-
sponse to different levels of extracellular signals of the TGF-β
superfamily. Whereas Activin and Bmp4 inhibit miR-125, Noggin and
the small molecule SB431542 promote miR-125 expression, which sub-
sequently inhibits SMAD4mediated transcriptional activation of its target
genes. This study demonstrates how miR-125 secures neural commit-
ment of human embryonic stem cells and gives further insight how
dual inhibition of SMAD signaling efﬁciently converts pluripotent cells
into a neural lineage [109].Reference
s neuronal differentiation [119]
es myoblast differentiation [120,121]
s dopaminergic differentiation
al neural stem cells
[122]
nic fate induction [123–125]
ve [124,126]
ins plasticity of helper T cells [127]
es osteogenic differentiation [128]
B-cell differentiation [129]
tiation of liver stem cells [130]
es endothelial tip cell fate and venous differentiation [131]
es neural transcriptome, neurogenic fate induction [126,132–135]
ural speciﬁcation [108]
cell proliferation and accelerates differentiation
l stem cells
[136]
es differentiation of pluripotent cells [111]
e smooth muscle cell differentiation [113]
methylation, cell cycle progression, regulation
entiation
[64,65,67,68,103]
es mesodermal lineage at the expense of mesoderm [102,137]
differentiation of postnatal myogenic progenitors [138]
chondrocyte and osteoblast maturation, redirect
hymal fate to adipogenic
[38]
Fig. 4. Regulation of cell fate by a network of miRNAs and transcription factor NF-κB. (A)
In embryonic stemcells (ESCs) a transcriptional network directed by the transcription fac-
tors Oct4 which can heterodimerize with Sox2 and its target gene Nanog direct the ex-
pression of miRNA cluster 290. Members of this cluster e.g. miR290 can repress
translation of NF-κB subunits such as RelA. FurthermoreNF-κB activity could be repressed
by direct interaction with Nanog. This repression seems to be crucial for the maintenance
of pluripotency. During differentiation a neural crest like neuroectodermal intermediate
(NC/NE) appeared, which relies on NF-κB activity. A high amount of NF-κB resulted in
the formation of mesoderm, whereas a low amount of NF-κB shifts cell fate from meso-
derm to neuroectoderm. (B) A similar regulation occurred during Drosophila develop-
ment. During the formation the dorso-ventral axis, the NF-κB ortholog Dorsal is
translocated to totipotent nuclei in the dorsal region. Nuclei within the syncythium
containing high amounts of Dorsal give rise tomesoderm,whereas nucleiwith intermedi-
ate levels of Dorsal are directed to a neuroectodermal cell fate (modiﬁed from [107]).
Fig. 5. General model for cell fate speciﬁcation by a network of miRNAs and transcription
factors. A transcription factor in an un-differentiated cell type (TF(u)) might regulate the
expression of a miRNA, which could destabilize the mRNA of a transcription factor induc-
ing differentiation (TF(d)). In a differentiated cell a transcription factor expressed in this
state might regulate amiRNA, which in turn inhibits the expression of a transcription fac-
tor necessary in un-differentiated cells. Thus, the combination of positively acting tran-
scription factors and negatively acting miRNA might stabilize cell fates.
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to be restricted to a speciﬁc lineage which rather indicates a general
involvement of these miRNAs in cellular differentiation. miRNA-145
for example has been proposed to be involved in regulating cell fate
decisions across different lineages [110–113].
Within the undifferentiated state of hESCs, miR-145 is only weakly
expressed, but dramatically upregulated during differentiation. Ectopicexpression of miR-145 causes loss of pluripotency by repressing Oct4,
Sox2 andKlf4 [111], whereas inhibition ofmiR-145 leads to an impaired
differentiation.
Another function of miR-145 is the regulation of smooth muscle
cell fate decisions [112,113]. miR-145 is transcripted as a bicistronic
primary transcript together with miR-143, the most enriched
miRNA during differentiation of mESCs into multipotent cardiac pro-
genitors. Expression of both miRNAs is controlled by the essential car-
diac transcription factors SRF (serum response factor) and NKx2.5
[113]. Knockout of miR-143 and miR-145 in mice revealed a crucial
role for both miRNAs in the differentiation of vascular smooth muscle
cells (VSMCs). Ablation of miR-143 and miR-145 resulted in structur-
al defects due to incomplete differentiation of VSMCs [112].
To further investigate the role of miR-145 or miR-143 in cell fate reg-
ulation, bothmiRNAswere tested for their ability tomodulatemyocardin
(myocd)-induced reprogramming of ﬁbroblasts into VSMCs [113].
Myocd is a smooth muscle and cardiac muscle-speciﬁc transcriptional
coactivator of serum response factor, which is able to induce
muscle-speciﬁc expression. Whereas miR-145 was able to strongly in-
crease theMyocdmediated conversion of ﬁbroblasts,miR-143 hadno ef-
fect. Without Myocod, miR-145 was not able to induce reprogramming
of ﬁbroblasts into VSMCs. The potential for miR-145 to trigger VSMC dif-
ferentiation was also demonstrated using multipotent neural crest stem
cells. In contrast to miR-143, which had no effect, miR-145 was able to
drive a large amount of these cells into VSMCs [113].
Though only miR-145 is capable to directly regulate smooth mus-
cle cell fate, both miRNAs cooperate to regulate a network of tran-
scription factors, resulting in the inhibition of proliferation and
entry into differentiation.6. Conclusion
miRNAs and their targets form tightly regulated networks that con-
trol pluripotency as well as differentiation processes into distinct line-
ages. Triggered by speciﬁc extracellular cues signaling cascades are
initiated determining cellular fates. Activation of lineage speciﬁc tran-
scription factors promotes the cellular programs which are necessary
for proper differentiation. Since their discovery a crucial role formiRNAs
has emerged during these processes. Maintenance of pluripotency as
well as differentiation of pluripotent stem cells depends on the action
of speciﬁc miRNAs. Within the pluripotent state, speciﬁc miRNAs re-
press transcription factors promoting cellular differentiation. Once
exit from self-renewal is committed, lineage-speciﬁc miRNAs are
upregulated inhibiting transcription factors speciﬁc for the pluripotent
state. Thereby, miRNAs ensure that the level of speciﬁc transcriptional
programs does not exceed a certain threshold and provides an addition-
al level of regulation (Fig. 5). In this context it is also noteworthy to
1901P. Lüningschrör et al. / Biochimica et Biophysica Acta 1833 (2013) 1894–1903speculate about themechanisms regulating the availability of functional
miRNAs. Recent studies indicate that miRNAs can also be regulated by
their targets, which creates the possibilities to form complex regulatory
loops enabling further options to adjust transcriptional program. This
regulatory mechanism also provides an option to adjust the availability
of functional miRNAs.
Though a large number of studies have been carried out to identify
miRNA regulated genes, the large number of potential targets regulated
by onemiRNAmakes it difﬁcult to unravel complete networks. Further-
more, somemiRNAs share the same seed sequences encoded at distinct
genetic loci, creating a functional redundancy that makes it difﬁcult to
carry out loss of function studies. In this line, knockout of speciﬁc
miRNAs in mice often results in partially penetrant phenotypes
[69,114–116], which might be explained by the function of miRNAs it-
self. Given that miRNAs have exclusively regulatory functions to confer
robustness to cellular processes [117], knockout cells or animals that
can adjust their transcriptional program do not develop a phenotype.
This adjustment can either be performed by the redundancy of seed se-
quences or by the randomness of gene expression during developmen-
tal processes even in genetically identical organism [118]. The fact that
miRNA targeting goes beyond the canonical seed match, even makes
the prediction of a subset of target sites even more difﬁcult.
Taken together, though a lot of studies during the last couple of
years shed some light into the role of miRNAmediated cell fate induc-
tion, the complete network of miRNAs and their targets still remains
elusive. Further studies will beneﬁt to our understanding how
miRNAs help to guide cells to their designated fate.
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